References and Research Abstracts Supporting Relax and Calm
1. Facts & Statistics. (n.d.). http://www.adaa.org/aboutadaa/press-room/facts-statistics
2. Chong Y, Fryar C, Gu Q. (2013). Prescription Sleep Aid Use Among Adults: United States, 2005–2010. Data Brief No. 127 U.S. Department of Health and Human Services Center For Disease Control and Prevention National Center for Health Statistics.
3. Kessler, Ronald C. et al. “Insomnia and the Performance of US Workers: Results from the America Insomnia Survey.” Sleep 34.9 (2011): 1161–1171.PMC. Web. 7 Sept. 2015.
4. Juneja, L. R., Chu, D. C., Okubo, T., Nagato, Y., & Yokogoshi, H. (1999). L-theanine—a unique amino acid of green tea and its relaxation effect in humans. Trends in Food Science & Technology, 10(6), 199-204.
5. Lu, K., Gray, M. A., Oliver, C., Liley, D. T., Harrison, B. J., Bartholomeusz, C. F., ... & Nathan, P. J. (2004). The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Human Psychopharmacology: Clinical and Experimental, 19(7), 457-465.
6. Kimura, K., Ozeki, M., Juneja, L. R., & Ohira, H. (2007). L-Theanine reduces psychological and physiological stress responses. Biological psychology, 74(1), 39-45.
7. Kakuda, T., Nozawa, A., Sugimoto, A., Nino, H., 2002. Inhibition by theanine of binding of [3H]AMPA, [3H] Kainate, and [3H]MDL 105,519 to glutamate receptors. Bioscience, Biotechnology, and Biochemistry 66, 2683– 2686.
8. Gyllenhaal C, Merritt SL, Peterson SD, Block KL, Gochenour T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med Rev 2000;4:229-51.
9. Meoli AL, Rosen C, Kristo D, et al. Oral nonprescription treatment for insomnia: An evaluation of products with limited evidence. J Clin Sleep Med 2005;1:173-87.
10. Stevenson C, Ernst E. Valerian for insomnia : A systematic review of randomized clinical trials. Sleep Med 2000;1:91-9.
11. Hallam KT, Olver JS, McGrath C, Norman TR. Comparative cognitive and psychomotor effects of single doses of valeriana officianalis and triazolam in healthy volunteers. Hum Psychopharmacol 2003;18:619- 25.
12. Maroo, N., Hazra, A., & Das, T. (2013). Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial. Indian journal of pharmacology, 45(1), 34.
13. Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005). Valerian-hops combination and diphenhydramine for treating insomnia: a randomized placebo-controlled clinical trial. SLEEP-NEW YORK THEN WESTCHESTER-, 28(11), 1465.
14. Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. Magnesium bioavailability from magnesium citrate and magnesium oxide. J Am Coll Nutr. 1990 Feb;9(1):48-55.
15. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other Mg preparations in a randomized, double-blind study. Magnes Res. 2003 Sep;16(3):183-91.